Related Experiment Video

Updated: Nov 29, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.5K

Cardiovascular Manifestations of COVID-19 Infection

Ajit Magadum1, Raj Kishore1,2

  • 1Center for Translational Medicine, Temple University, Philadelphia, PA 19140, USA.

Cells
|November 24, 2020
PubMed

Insights

The SARS-CoV-2 virus, causing COVID-19, significantly increases cardiovascular disease severity and fatality. Understanding virus-induced heart damage mechanisms is crucial for developing targeted therapies to prevent long-term cardiac complications.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Virology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, presents a major global health crisis.
  • Preexisting conditions like cardiovascular disease (CVD), diabetes, hypertension, and obesity are linked to increased COVID-19 severity and mortality.
  • COVID-19 is associated with various cardiovascular complications, including myocarditis, arrhythmias, and heart failure.

Purpose of the Study:

  • To review the current understanding of cardiovascular damage induced by SARS-CoV-2.
  • To explore proposed mechanisms of myocardial injury caused by the virus.
  • To highlight the need for novel therapeutic strategies to mitigate virus-induced cardiac damage.

Main Methods:

  • Systematic review of current scientific literature on COVID-19 and cardiovascular effects.
  • Analysis of proposed pathogenic mechanisms, including direct viral effects and indirect inflammatory responses.
  • Discussion of the role of the ACE2 receptor in SARS-CoV-2 pathogenesis.

Main Results:

  • SARS-CoV-2 infection can lead to diverse cardiovascular complications.
  • Potential mechanisms include direct viral myocardial invasion, systemic inflammation, hypoxia, and cytokine storms.
  • The angiotensin-converting enzyme-2 (ACE2) receptor is implicated in viral entry and pathogenesis.

Conclusions:

  • A comprehensive understanding of SARS-CoV-2's cardiovascular impact is essential.
  • Developing targeted therapies is critical to minimize permanent cardiac damage and reduce morbidity.
  • Further research is needed to elucidate the precise mechanisms of virus-induced myocardial injury.

Keywords:
COVID-19SARS-CoV-2angiotensin converting enzyme-2cardiovascular diseasecytokine storm and inflammationmyocardial injury

More Related Videos

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome06:04

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome

Published on: September 27, 2024

1.2K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.8K

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
188
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
204
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
198
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
118
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
219
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
221